Abstract:Quinoxolinehydrazines represent a novel class of compounds with excellent potency in a panel of cancer cell lines. A prototype compound, SC144, showed significant in vivo efficacy in mice xenogroft models of human breast cancer cells. The subsequent structure-activity relationship study resulted in the discovery of SC161 with better potency in cancer cell lines. Further exploring the possible conformational space by a 10 ns molecular dynamics simulation as presented herein, resulted in various pharmacophore orientations. The trajectory analysis indicated that in most of the simulation time, the molecule stays favorably in a compact planarlike orientation. We therefore built a pharmacophore model based on the cluster containing the highest number of frames to represent the most probable orientation. The model was used to screen a subset of our small molecule database containing 350,000 compounds. We selected 35 compounds for the initial cytotoxicity screen. Seventeen compounds belonging to oxadiazolopyrazine and quinoline class displayed cytotoxicity in various cancer cell lines. Five of them, compounds 2 6, 15, 16, and 19, all bearing an oxadiazolopyrazine scaffold, showed IC(50) values <3 mu M in certain tumor cell lines. The most potent compound, 2, showed IC(50) values <2 mu M in HCT116 p53(+/+), HCT116 p53(-/-), and HEY cells, and 8 mu M in NIH3T3 cells. This study shows that conformational sampling of a lead small molecule followed by representative pharmocophore model development is an efficient approach for the rational design of novel anticancer agents with similar or better potency than the original lead but with different physicochemical properties.

Rapid Assembly of 1,3-Indanedione-based Spirocyclic Tetrahydroquinolines for Inducing Human Lung Cancer Cell Apoptosis

Synthesis, Crystal Structure and Evaluation of Cancer Inhibitory Activity of 4-[Indol-3-yl-methylene]-1h-pyrazol-5(4h)-one Derivatives

Molecular Hybridization-Guided 1,3-Dipolar Cycloaddition Reaction Enabled Pyrimidine-Fused Spiropyrrolidine Oxindoles Synthesis As Potential Anticancer Agents

Synthesis And Biological Evaluation Of 3-Aryl-Quinoxaline-2-Carbonitrile 1,4-Di-N-Oxide Derivatives As Hypoxic Selective Anti-Tumor Agents

Design, Synthesis and Biological Evaluation of 6-(Nitroimidazole-1h-alkyloxyl)-4-anilinoquinazolines As Efficient EGFR Inhibitors Exerting Cytotoxic Effects Both under Normoxia and Hypoxia.

A Facile and Efficient Synthesis of Hexahydro-1H-pyrido[2,3-b]indol-2-one Scaffolds Via a Sequential Michael Addition/amidation/reductive Cyclization Process

Efficient assembly and anti-tumor evaluation of novel polycyclic [1,2-a]-fused indoles

Synthesis and Biological Evaluation of 3-Aryl-quinoxaline-2-carbonitrile 1,4-Di-<em>N</em>-oxide Derivatives as Hypoxic Selective Anti-tumor Agents

Design, Synthesis and Biological Evaluation of Novel Antitumor Spirodihydrothiopyran-Oxindole Derivatives

Construction of Turmerone Motif-Fused Spiropyrrolidine Oxindoles and Their Biological Evaluation for Anticancer Activities

Synthesis and Antitumor Activities of Novel Pyrimidine-fused Spiropyrrolidine Oxindoles

Discovery of 1,4-Pentadien-3-one Derivatives Containing Quinoxaline Scaffolds As Potential Apoptosis Inducers.

Diversity-oriented TsOH Catalysis-Enabled Construction of Tanshinone-Substituted Bis(indolyl/pyrrolyl)methanes and Their Biological Evaluation for Anticancer Activities

Synthesis and in Vitro Evaluation of Pyrimidine-Fused 3-Alkenyloxindoles As Potential Anticancer Agents

Discovery of Novel Anticancer Compounds Based on a Quinoxalinehydrazine Pharmacophore.

Synthesis of quinoxalines and assessment of their inhibitory effects against human non-small-cell lung cancer cells

Diversity-oriented One-Pot Multicomponent Synthesis of Spirooxindole Derivatives and Their Biological Evaluation for Anticancer Activities

Design and Synthesis of 6,7-Methylenedioxy-4-substituted Phenylquinolin-2(1H)-one Derivatives As Novel Anticancer Agents That Induce Apoptosis with Cell Cycle Arrest at G2/M Phase

One-pot synthesis of natural-product inspired spiroindolines with anti-cancer activities

Regio- and stereoselective synthesis and evaluation of densely functionalized bispiro[oxindole-isoxazole-indandione] hybrids as anticancer agents

Synthesis of Antitumor 3,4,6,7-Tetrahydro-2h-pyrimido[1,6-c]quinazolin-2-imine Derivatives Via Reductive Dearomatization-Initiated Intramolecular Cyclization